GSK plc (GSK) is expected to report earnings on Wednesday, October 28, 2026, after the close. Consensus EPS estimate is $1.37.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-29 | FY2026 Q1 | $1.16 | $0.86 | -25.9% | $7.63B |
| 2026-02-04 | FY2025 Q4 | $0.64 | $0.32 | -50.0% | $8.62B |
| 2025-10-28 | FY2025 Q3 | $1.26 | $1.00 | -20.6% | $8.55B |
| 2025-07-30 | FY2025 Q2 | $1.12 | $0.72 | -35.7% | $7.99B |
| 2025-04-30 | FY2025 Q1 | $1.08 | $0.80 | -25.9% | $7.52B |
| 2025-02-05 | FY2024 Q4 | $0.44 | $0.20 | -54.5% | $8.12B |
| 2024-07-31 | FY2024 Q2 | $1.00 | $0.58 | -42.0% | $7.88B |
| 2024-05-01 | FY2024 Q1 | $0.91 | $0.52 | -42.9% | $7.36B |
GSK has beaten consensus EPS in 0 of its last 8 reported quarters.
See GSK on the live calendar →